Clinical Research Directory
Browse clinical research sites, groups, and studies.
Opioid Use Disorder Treatment Linkage at Strategic Touchpoints Using Buprenorphine
Sponsor: Friends Research Institute, Inc.
Summary
This study will examine the effectiveness of opioid use disorder (OUD) treatment linkage strategies for patients identified at sexual health clinics and through community outreach and referrals. This 3-arm RCT will compare Usual Care vs. Patient Navigation vs. Patient Navigation + Buprenorphine Initiation (UC vs. PN vs. PN+BUP).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
373
Start Date
2021-09-17
Completion Date
2026-01-31
Last Updated
2026-05-29
Healthy Volunteers
No
Conditions
Interventions
Patient Navigation
A Patient Navigator will work with participants to facilitate their entry into OUD treatment in the community (e.g., by selecting a program, scheduling intake appointments, and addressing barriers to facilitate successful treatment linkage).
Buprenorphine
Buprenorphine is an FDA-approved medication for opioid dependence, and will be used in this study consistent with its approved use (but will be initiated in the novel setting of sexual health clinics in this health services study). Participants will meet with an sexual health clinic provider who holds a waiver to prescribe buprenorphine. Participants will initiate buprenorphine treatment via a home induction under the direction of the provider. Because barriers to transfer may take some time to overcome, participants will be able to receive additional bridge buprenorphine up to two times (up to 15 days' supply at a time) until successful transfer to OUD treatment in the community.
Locations (2)
Friends Research Institute
Baltimore, Maryland, United States
Baltimore City Health Department Sexual Health Clinics
Baltimore, Maryland, United States